Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs

    NEXT STORY
    Oasmia Pharmaceutical Strengthens its Management Team and Organization
    PREV STORY
    MediciNova Announces MN-001 Research Collaboration with The Jikei University School of Medicine in Tokyo, Japan
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Flexion Therapeutics Reports Third-Quarter 2018 Financial Results and Recent Business Highlights

    Company reported net ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) sales of $7.0 million in ...

    author_avatar
    NASDAQ Market News

    Immunomodulation Therapies Announces Formation of Scientific Advisory Board and Appointment of Robert V. Stahelin, Ph.D. as Inaugural Member

    NORTHBROOK, Ill., July 31, 2018 (GLOBE NEWSWIRE) -- Immunomodulation Inc. ("Immunomodulation" or the "Company"), ...

    author_avatar
    NASDAQ Market News

    Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum

    author_avatar
    NASDAQ Market News